SIMULTANEOUS EVALUATION OF CYP2D6, CYP2C9, CYP2C19, CYP3A4, CYP1A2 HYDROXYLATION CAPACITY IN HUMANS

F De Andres; Markus Paulmichl; A Llerena

SIMULTANEOUS EVALUATION OF CYP2D6, CYP2C9, CYP2C19, CYP3A4, CYP1A2 HYDROXYLATION CAPACITY IN HUMANS

F De Andres
, Markus Paulmichl
, A Llerena

Institute of Pharmacology and Toxicology

Research output: Contribution to journal › Abstract (Journal) › peer-review

Original language	English
Pages (from-to)	S61-S61
Journal	CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume	93
Publication status	Published - 2013
Event	Annual Meeting of the American-Society-for-Clinical-Pharmacology-and-Therapeutics (ASCPT) / Quantitative Systems Pharmacology - An Integrating Framework for Translational Medicine Pre-Conference - Indianapolis, IN Duration: 5 Mar 2013 → 9 Mar 2013

Cite this

De Andres, F., Paulmichl, M., & Llerena, A. (2013). SIMULTANEOUS EVALUATION OF CYP2D6, CYP2C9, CYP2C19, CYP3A4, CYP1A2 HYDROXYLATION CAPACITY IN HUMANS. CLINICAL PHARMACOLOGY & THERAPEUTICS , 93, S61-S61.

De Andres, F ; Paulmichl, Markus ; Llerena, A. / SIMULTANEOUS EVALUATION OF CYP2D6, CYP2C9, CYP2C19, CYP3A4, CYP1A2 HYDROXYLATION CAPACITY IN HUMANS. In: CLINICAL PHARMACOLOGY & THERAPEUTICS 2013 ; Vol. 93. pp. S61-S61.

@article{35ca61565d694e308fd55a504271331b,

title = "SIMULTANEOUS EVALUATION OF CYP2D6, CYP2C9, CYP2C19, CYP3A4, CYP1A2 HYDROXYLATION CAPACITY IN HUMANS",

author = "\{De Andres\}, F and Markus Paulmichl and A Llerena",

year = "2013",

language = "English",

volume = "93",

pages = "S61--S61",

journal = "CLINICAL PHARMACOLOGY \& THERAPEUTICS ",

issn = "0009-9236",

note = "Annual Meeting of the American-Society-for-Clinical-Pharmacology-and-Therapeutics (ASCPT) / Quantitative Systems Pharmacology - An Integrating Framework for Translational Medicine Pre-Conference ; Conference date: 05-03-2013 Through 09-03-2013",

}

De Andres, F, Paulmichl, M & Llerena, A 2013, 'SIMULTANEOUS EVALUATION OF CYP2D6, CYP2C9, CYP2C19, CYP3A4, CYP1A2 HYDROXYLATION CAPACITY IN HUMANS', CLINICAL PHARMACOLOGY & THERAPEUTICS , vol. 93, pp. S61-S61.

SIMULTANEOUS EVALUATION OF CYP2D6, CYP2C9, CYP2C19, CYP3A4, CYP1A2 HYDROXYLATION CAPACITY IN HUMANS. / De Andres, F; Paulmichl, Markus; Llerena, A.
In: CLINICAL PHARMACOLOGY & THERAPEUTICS , Vol. 93, 2013, p. S61-S61.

Research output: Contribution to journal › Abstract (Journal) › peer-review

TY - JOUR

T1 - SIMULTANEOUS EVALUATION OF CYP2D6, CYP2C9, CYP2C19, CYP3A4, CYP1A2 HYDROXYLATION CAPACITY IN HUMANS

AU - De Andres, F

AU - Paulmichl, Markus

AU - Llerena, A

PY - 2013

Y1 - 2013

M3 - Abstract (Journal)

SN - 0009-9236

VL - 93

SP - S61-S61

JO - CLINICAL PHARMACOLOGY & THERAPEUTICS

JF - CLINICAL PHARMACOLOGY & THERAPEUTICS

T2 - Annual Meeting of the American-Society-for-Clinical-Pharmacology-and-Therapeutics (ASCPT) / Quantitative Systems Pharmacology - An Integrating Framework for Translational Medicine Pre-Conference

Y2 - 5 March 2013 through 9 March 2013

ER -

De Andres F, Paulmichl M, Llerena A. SIMULTANEOUS EVALUATION OF CYP2D6, CYP2C9, CYP2C19, CYP3A4, CYP1A2 HYDROXYLATION CAPACITY IN HUMANS. CLINICAL PHARMACOLOGY & THERAPEUTICS . 2013;93:S61-S61.